Abstract
In contrast to Yersinia pestis LcrV, the recombinant V10 (rV10) variant (lacking residues 271 to 300) does not suppress the release of proinflammatory cytokines by immune cells. Immunization with rV10 generates robust antibody responses that protect mice against bubonic plague and pneumonic plague, suggesting that rV10 may serve as an improved plague vaccine.
| Original language | English |
|---|---|
| Pages (from-to) | 4910-4914 |
| Number of pages | 5 |
| Journal | Infection and Immunity |
| Volume | 74 |
| Issue number | 8 |
| DOIs | |
| State | Published - Aug 2006 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver